Nanoengineered biomaterials for advanced drug delivery / (Record no. 82453)

000 -LEADER
fixed length control field 05316cam a2200637 a 4500
001 - CONTROL NUMBER
control field on1159162541
003 - CONTROL NUMBER IDENTIFIER
control field OCoLC
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20230516165856.0
006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS
fixed length control field m o d
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr un|---aucuu
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 200620s2020 ne o 001 0 eng d
040 ## - CATALOGING SOURCE
Original cataloging agency EBLCP
Language of cataloging eng
Description conventions pn
Transcribing agency EBLCP
Modifying agency YDX
-- OPELS
-- UKAHL
-- OCLCF
-- UKMGB
-- N$T
-- OCLCQ
-- OCLCO
-- K6U
-- OCLCQ
015 ## - NATIONAL BIBLIOGRAPHY NUMBER
National bibliography number GBC075827
Source bnb
016 7# - NATIONAL BIBLIOGRAPHIC AGENCY CONTROL NUMBER
Record control number 019819556
Source Uk
019 ## -
-- 1159206835
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 0081029861
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9780081029862
Qualifying information (electronic bk.)
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 9780081029855
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
Canceled/invalid ISBN 0081029853
035 ## - SYSTEM CONTROL NUMBER
System control number (OCoLC)1159162541
Canceled/invalid control number (OCoLC)1159206835
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number R857.M3
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 610.28
Edition number 23
245 00 - TITLE STATEMENT
Title Nanoengineered biomaterials for advanced drug delivery /
Statement of responsibility, etc. edited by Masoud Mozafari.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Place of publication, distribution, etc. Amsterdam :
Name of publisher, distributor, etc. Elsevier,
Date of publication, distribution, etc. 2020.
300 ## - PHYSICAL DESCRIPTION
Extent 1 online resource (826 pages)
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
490 1# - SERIES STATEMENT
Series statement Woodhead Publishing Series in Biomaterials
588 0# - SOURCE OF DESCRIPTION NOTE
Source of description note Print version record.
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Intro -- Nanoengineered Biomaterials for Advanced Drug Delivery -- Copyright -- Contents -- Contributors -- Preface -- Acknowledgment -- Part One Principles of nanotechnology-based drug delivery -- 1 Principles of nanosized drug delivery systems -- 1.1 Introduction -- 1.2 What are nanosized drug delivery systems and why they are useful? -- 1.3 Different types of nanodelivery systems -- 1.3.1 Polymeric nanoparticles -- 1.3.2 Liposomes -- 1.3.3 Niosomes -- 1.3.4 Solid lipid nanoparticles -- 1.3.5 Micro- and nanoemulsions -- 1.3.6 Polymeric micelles -- 1.3.7 Dendrimers
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 1.3.8 Inorganic nanoparticles and quantum dots -- 1.3.9 Nanocrystals -- 1.3.10 Protein-based and natural biopolymer-based nanoparticles -- 1.4 Particle properties and related biobarrier interactions of nanosystems -- 1.4.1 Opsonization and phagocytosis -- 1.4.2 Particle size -- 1.4.3 Shape -- 1.4.4 Surface charge -- 1.4.5 Hydrophilic/hydrophobic character -- 1.4.6 Other factors -- 1.5 Nanoparticles in medicines -- 1.5.1 Lipid nanotechnology -- 1.5.2 Nanoparticle nanotechnology -- 1.6 Conclusions -- References -- 2 Controlled/localized release and nanotechnology -- 2.1 Introduction
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 2.2 The evolution of drug delivery systems -- 2.3 Nanostructures from dimension viewpoint -- 2.3.1 Zero-dimensional nanostructures -- 2.3.2 One-dimensional nanostructures -- 2.3.3 Two-dimensional nanostructures -- 2.3.4 Three-dimensional nanostructures -- 2.4 Bionanostructures -- 2.5 Micro- and nanomotors -- 2.6 Conclusion -- References -- 3 Stimuli-sensitive drug delivery systems -- 3.1 Introduction -- 3.2 pH-sensitive drug delivery systems -- 3.3 Redox-sensitive drug delivery systems -- 3.4 Thermosensitive drug delivery systems -- 3.5 Magnetically sensitive drug delivery systems
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 3.6 Ultrasound-sensitive drug delivery systems -- 3.7 Photosensitive drug delivery systems -- 3.8 Electrosensitive drug delivery systems -- 3.8.1 Intrinsically conducting polymers -- 3.8.2 Hydrogels -- 3.9 Enzyme-sensitive drug delivery systems -- 3.10 Dual- and multisensitive drug delivery systems -- 3.11 Conclusions -- References -- 4 Sustainable drug delivery systems through green nanotechnology -- 4.1 Nanotechnology -- 4.2 Green nanotechnology -- 4.3 Green nanotechnology in drug delivery -- 4.4 Classification of nanoparticles -- 4.4.1 Liposomes -- 4.4.2 Polymeric nanoparticles
505 8# - FORMATTED CONTENTS NOTE
Formatted contents note 4.4.3 Dendrimer -- 4.4.4 Quantum dots -- 4.4.5 Silica nanoparticles -- 4.4.6 Magnetic nanoparticles -- 4.5 Metal-organic frameworks -- 4.6 Green methods for synthesis of MOFs -- 4.6.1 Mechanochemistry -- 4.6.2 Sonochemistry -- 4.6.3 Microwave -- 4.7 Synthesis of MOFs by using bioactive molecules -- 4.8 Summary -- References -- Further reading -- 5 Recent advances in multifunctional nanoengineered biomaterials -- 5.1 Introduction -- 5.2 Recent advances in imaging techniques -- 5.2.1 Optical imaging -- 5.2.2 Photoacoustic imaging -- 5.2.3 Multimodality imaging
500 ## - GENERAL NOTE
General note 5.3 Recent advances in biomedical applications
500 ## - GENERAL NOTE
General note Includes index.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nanostructured materials.
9 (RLIN) 4537
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomedical materials.
9 (RLIN) 3868
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug delivery systems.
9 (RLIN) 7290
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nanostructures
Authority record control number or standard number (DNLM)D049329
9 (RLIN) 5928
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biocompatible Materials
Authority record control number or standard number (DNLM)D001672
9 (RLIN) 5921
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomedical and Dental Materials
Authority record control number or standard number (DNLM)D001697
9 (RLIN) 68432
650 #2 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug Delivery Systems
Authority record control number or standard number (DNLM)D016503
9 (RLIN) 7290
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nanomat�eriaux.
Authority record control number or standard number (CaQQLa)201-0258061
9 (RLIN) 68453
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomat�eriaux.
Authority record control number or standard number (CaQQLa)201-0025723
9 (RLIN) 68433
650 #6 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Syst�emes d'administration de m�edicaments.
Authority record control number or standard number (CaQQLa)000260397
9 (RLIN) 68784
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomedical materials.
Source of heading or term fast
Authority record control number or standard number (OCoLC)fst00832586
9 (RLIN) 3868
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Drug delivery systems.
Source of heading or term fast
Authority record control number or standard number (OCoLC)fst00898667
9 (RLIN) 7290
650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nanostructured materials.
Source of heading or term fast
Authority record control number or standard number (OCoLC)fst01032630
9 (RLIN) 4537
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Mozafari, Masoud.
9 (RLIN) 68785
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Print version:
Main entry heading Mozafari, Masoud.
Title Nanoengineered Biomaterials for Advanced Drug Delivery.
Place, publisher, and date of publication San Diego : Elsevier, �2020
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Woodhead Publishing series in biomaterials.
9 (RLIN) 68481
856 40 - ELECTRONIC LOCATION AND ACCESS
Materials specified ScienceDirect
Uniform Resource Identifier <a href="https://www.sciencedirect.com/science/book/9780081029855">https://www.sciencedirect.com/science/book/9780081029855</a>
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Koha item type eBooks

No items available.